Angel Aledo-Serrano: Impact of delayed treatment or medication switch in Epilepsy

"Time is brain" – learn how early seizure control, timely surgery, and treatment strategies impact morbidity, mortality, and long-term outcomes in epilepsy.

  1. Home
  2. Epilepsy Education
  3. From Now On: Advancing Epilepsy Education and Care
  4. Seminars
  5. You are here: Angel Aledo-Serrano: Impact of delayed treatment or medication switch in Epilepsy

Seminar

Introduction

In his talk dr. Aledo-Serrano shared the concept of “time is brain” when discussing about increased risk of morbidity and mortality with epilepsy and how treatment practices are reflected in real-world studies. The duration of epilepsy before epilepsy surgery predicts surgery outcome1 whereas baseline ASM polytherapy is associated with a reduced risk of early death2. Evidence indicates that earlier and effective seizure control is considered essential for optimal outcomes.

Dr. Angel Aledo-Serrano (MD, PhD) is director of the Vithas Clinical Neuroscience Institute at Vithas University Hospitals, Madrid, Spain

  1. Radhakrishnan A, Menon R, Thomas SV et al. “Time is Brain”—How early should surgery be done in drug-resistant TLE? Acta Neur Scan. 2018;138(6):531-40
  2. Hrabok M, Engbers JDT, Wiebe S et al. Primary care electronic medical records can be used to predict risk and identify potentially modifiable factors for early and late death in adult onset epilepsy. 2021;62:51-60
MAT-SE-0042-P 6.10.2025

Explore more